ADMA Biologics ADMA reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
ADMA Biologics beat estimated earnings by 12.5%, reporting an EPS of $-0.07 versus an estimate of $-0.08.
Revenue was up $16.07 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 17.48% increase in the share price the next day.
Here’s a look at ADMA Biologics’s past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for ADMA Biologics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.